Detalhe da pesquisa
1.
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee.
Blood
; 2024 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38493484
2.
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes.
Blood
; 2024 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687605
3.
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes.
Blood
; 141(17): 2047-2061, 2023 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36724453
4.
Immune reconstitution after single-unit umbilical cord blood transplantation using anti-thymoglobulin and myeloablative conditioning in adults with hematological malignancies.
Ann Hematol
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38634914
5.
Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registry.
Br J Haematol
; 200(4): 451-461, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36335984
6.
Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study.
Blood
; 138(16): 1429-1440, 2021 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34157093
7.
STIMULUS-MDS2 design and rationale: a phase III trial with the anti-TIM-3 sabatolimab (MBG453) + azacitidine in higher risk MDS and CMML-2.
Future Oncol
; 19(9): 631-642, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37083373
8.
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.
BMC Cancer
; 22(1): 1013, 2022 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36153475
9.
Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology Added Value Framework for Hematologic Malignancies: A Comparative Analysis of Existing Tools.
Value Health
; 25(10): 1760-1767, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35595634
10.
Myelodysplastic syndromes with 20q deletion: incidence, prognostic value and impact on response to azacitidine of ASXL1 chromosomal deletion and genetic mutations.
Br J Haematol
; 194(4): 708-717, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34296432
11.
Ex vivo T-cell depletion vs post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft-vs-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation.
Eur J Haematol
; 106(1): 114-125, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33025625
12.
Adoptive transfer of ex vivo expanded SARS-CoV-2-specific cytotoxic lymphocytes: A viable strategy for COVID-19 immunosuppressed patients?
Transpl Infect Dis
; 23(4): e13602, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33728702
13.
Impact of the SARS-CoV-2 (COVID19) pandemic on the morbidity and mortality of high risk patients undergoing surgery: a non-inferiority retrospective observational study.
BMC Anesthesiol
; 21(1): 295, 2021 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34836504
14.
Multicolor Imaging for the Detection of Inner Nuclear Layer Microcysts Secondary to Optic Nerve Atrophy.
J Neuroophthalmol
; 41(1): e107-e110, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33587537
15.
Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies.
Biol Blood Marrow Transplant
; 26(2): 358-366, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31655119
16.
Partial T Cell-Depleted Peripheral Blood Stem Cell Transplantation from HLA-Identical Sibling Donors for Patients with Severe Aplastic Anemia.
Biol Blood Marrow Transplant
; 26(1): 83-87, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493538
17.
Development of a core outcome set for myelodysplastic syndromes - a Delphi study from the EUMDS Registry Group.
Br J Haematol
; 191(3): 405-417, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32410281
18.
Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia.
Br J Haematol
; 188(5): 605-622, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31621063
19.
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry.
Haematologica
; 105(3): 640-651, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31278207
20.
Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes.
Haematologica
; 105(3): 632-639, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31171638